Literature DB >> 30354013

Efficacy of Additional Corticosteroid in a Multimodal Cocktail for Postoperative Analgesia Following Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.

Xiping Chai1, Haiping Liu1, Congxin You1, Changde Wang1,2.   

Abstract

BACKGROUND: Local injection of a multimodal cocktail including corticosteroid is commonly used for postoperative pain following total knee arthroplasty (TKA). However, it is inconclusive whether additional corticosteroid is beneficial. This meta-analysis of randomized controlled trials (RCTs) aimed to evaluate the efficacy of an additional, local injection of corticosteroid in terms of pain relief and knee function recovery after TKA.
METHODS: RCTs in electronic literature databases including PubMed, Web of Science, Embase, and Cochrane Library were systematically searched. Of 1,628 records identified, 9 RCTs involving 727 knees were eligible for data extraction and meta-analysis.
RESULTS: Local injection of a multimodal cocktail including corticosteroid did not contribute to pain relief within 12 hours postoperatively (P > 0.05). However, from 24 hours to 72 hours, it significantly decreased pain scores (P < 0.05, all) at rest and reduced total rescue opioid consumption postoperatively (P < 0.05). Knee range of motion (ROM) was improved at postoperative day 1 (POD1) and POD2 (P < 0.05), and hospital stay (P < 0.05) was shortened after local injection of corticosteroid. However, the other outcomes, including knee ROM after POD2, C-reactive protein level, Knee Society score, postoperative nausea and vomiting, and wound complication occurrences, were not significantly different (P > 0.05, all).
CONCLUSIONS: Additional corticosteroid added to a multimodal cocktail improved postoperative pain, enhanced knee functional recovery, and shortened hospital stays following TKA, but local injection of corticosteroids had no effect on reducing nausea and vomiting based on our outcomes.
© 2018 World Institute of Pain.

Entities:  

Keywords:  corticosteroid; postoperative pain; total knee arthroplasty

Mesh:

Substances:

Year:  2019        PMID: 30354013     DOI: 10.1111/papr.12740

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  6 in total

1.  Perioperative steroid administration improves knee function and reduces opioid consumption in bilateral total knee arthroplasty.

Authors:  David Keohane; Gerard Sheridan; James Harty
Journal:  J Orthop       Date:  2020-10-07

2.  Low-Dose Perioperative Corticosteroids Can Be Administered Without Additional Morbidity in Patients Undergoing Bilateral Total Knee Replacement: A Retrospective Follow-up Study of a Randomized Controlled Trial.

Authors:  Alexander S McLawhorn; Lazaros A Poultsides; Vasileios I Sakellariou; Kyle N Kunze; Kara G Fields; Kethy Jules-Elysée; Thomas P Sculco
Journal:  HSS J       Date:  2021-04-09

3.  Adductor canal block combined with local infiltration analgesia with morphine and betamethasone show superior analgesic effect than local infiltration analgesia alone for total knee arthroplasty: a prospective randomized controlled trial.

Authors:  Zhen-Yu Luo; Qiu-Ping Yu; Wei-Nan Zeng; Qiang Xiao; Xi Chen; Hao-Yang Wang; Zongke Zhou
Journal:  BMC Musculoskelet Disord       Date:  2022-05-19       Impact factor: 2.562

4.  Effect of flurbiprofen axetil combined with "Cocktail" therapy on opioid dosage in patients after total knee arthroplasty.

Authors:  Lu Wang; Li-Xin Wu; Zhe Han; Wen-Hai Ma; Zhi-Hui Geng
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 1.088

5.  Low-dose Perioperative Dexamethasone Improves 24-hour Post-Operative Pain after Anterior Cruciate Ligament Reconstruction.

Authors:  K Khatri; G Sidhu; S Jindal; D Bansal; D Goyal
Journal:  Malays Orthop J       Date:  2022-03

6.  The Effects of Periarticular Injection Cocktail in Postoperative Analgesia after Bilateral Unicompartmental Knee Arthroplasty.

Authors:  Ruizhu Wang; Jin Zhao; Xiaojing Guo; Binping Ji
Journal:  Comput Math Methods Med       Date:  2022-07-28       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.